{
    "2021-11-29": [
        [
            {
                "time": "",
                "original_text": "医药行业周报：OMICRON成热议 CDMO和上游边际改善",
                "features": {
                    "keywords": [
                        "OMICRON",
                        "CDMO",
                        "上游",
                        "边际改善"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "新冠检测概念股大涨！个股研发成色如何？这家公司研发投入占比仅0.0158%",
                "features": {
                    "keywords": [
                        "新冠检测",
                        "概念股",
                        "研发投入"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药股早间分化 复星医药早间获主力抢筹超亿元",
                "features": {
                    "keywords": [
                        "医药股",
                        "复星医药",
                        "主力抢筹"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "解盘：股指震荡走高，锂电、储能、肺炎检测领涨",
                "features": {
                    "keywords": [
                        "股指",
                        "锂电",
                        "储能",
                        "肺炎检测"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "今日港股生物医药板块持续走高，开拓药业等涨近11%",
                "features": {
                    "keywords": [
                        "港股",
                        "生物医药",
                        "开拓药业"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业创新药周报：OMICRON毒株异军来袭 新冠药物研发快速推进",
                "features": {
                    "keywords": [
                        "创新药",
                        "OMICRON",
                        "新冠药物",
                        "研发"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[异动股]复星医药(02196.HK)涨4.45%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "异动股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[行情]港股抗疫概念股普涨，开拓药业(09939.HK)涨10.8%，复星医药(02196.HK)涨6.73%，君实生物(01877.HK)涨5.9%，中国生物制药(01177.HK)涨3.56%",
                "features": {
                    "keywords": [
                        "港股",
                        "抗疫概念",
                        "开拓药业",
                        "复星医药",
                        "君实生物",
                        "中国生物制药"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "港股抗疫概念逆势大涨，开拓药业、康希诺生物一度涨超10%",
                "features": {
                    "keywords": [
                        "港股",
                        "抗疫概念",
                        "开拓药业",
                        "康希诺生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "私募EB每周跟踪：可交换私募债跟踪",
                "features": {
                    "keywords": [
                        "私募EB",
                        "可交换私募债"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "智通港股早知道 | (11月29日) Omicron变异新冠病毒引担忧，烟草专卖法实施条例修改落地",
                "features": {
                    "keywords": [
                        "Omicron",
                        "烟草专卖法",
                        "实施条例"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "消费品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "门槛将大幅提高，互联网医疗行业告别“野蛮生长”",
                "features": {
                    "keywords": [
                        "互联网医疗",
                        "门槛提高",
                        "野蛮生长"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "互联网"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}